Thermo Fisher Scientific (TMO) DIvidends Date & History

Key Takeaways

• TMO offers a low current dividend yield of approximately 0.29% with an annual payout of $1.88 per share.
• The company pays dividends quarterly and has increased its dividend for 8 consecutive years.
• Payout ratio remains very low at around 10%, indicating strong earnings coverage and sustainability.
• Dividend growth has averaged over 12% annually over the past five years.
• TMO suits dividend growth investors seeking capital appreciation over high current income.
• Free cash flow comfortably supports the dividend with significant headroom for future increases.

Dividend Overview

Thermo Fisher Scientific Inc. (TMO) maintains a conservative dividend policy focused on sustainable growth rather than high yields. The stock currently delivers an annual dividend of $1.88 per share, resulting in a yield of roughly 0.29% based on recent share prices near $650. Payments occur quarterly at $0.47 per share. This profile positions TMO as a dividend growth stock with a modest yield, appealing to investors prioritizing long-term income expansion over immediate high returns. The company has prioritized reinvestment in its life sciences and analytical instruments business while gradually expanding shareholder returns.

Dividend History and Growth

TMO has built a consistent dividend track record since initiating regular payments. The company has raised its dividend annually for eight consecutive years. Recent quarterly amounts increased from $0.39 in early 2024 to $0.47 by mid-2026. Over the past five years, the annualized dividend growth rate has exceeded 12%. This steady progression reflects a deliberate strategy to return capital to shareholders while funding research, acquisitions, and operational expansion in the healthcare sector.

Dividend Sustainability and Payout Ratio

The dividend appears highly sustainable. TMO’s payout ratio stands at approximately 10%, well below typical thresholds for concern and significantly lower than many peers. Earnings and free cash flow provide ample coverage, with the company generating robust cash flows from its diversified portfolio of scientific instruments, reagents, and services. Low debt levels relative to earnings further support ongoing dividend payments and potential future growth. No signs of strain appear in recent financial metrics.

Dividend Compared to Industry Peers

Within the healthcare sector, TMO’s yield of 0.29% ranks below the approximate 2.53% average for healthcare companies. Many peers in pharmaceuticals and medical devices offer higher current yields but often with less emphasis on rapid dividend growth. TMO’s combination of low payout ratio and consistent increases differentiates it as a growth-oriented option rather than a high-income play.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to discover similar opportunities.

Is This Stock Attractive for Dividend Investors?

TMO may appeal to dividend growth investors and long-term holders who value consistent annual increases and financial strength over high current yields. Income-focused investors seeking immediate cash flow might find the modest yield less attractive compared to higher-yielding healthcare peers. Conservative investors could appreciate the low payout ratio and strong balance sheet as indicators of resilience. The stock suits portfolios emphasizing total return through a balance of modest income and capital appreciation potential, particularly for those with a multi-year horizon. Investors should evaluate their own income needs and risk tolerance when considering allocation.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations